NCT04501393

Brief Summary

Research in developing patient fasting guidelines was developed years ago. On a physiological basis, patients with a longer fasting time may have less residual gastric content and lower risk of pulmonary aspiration. The recent Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration of The American Society of Anesthesiologists (ASA) was published in March 2017. Current practice consists of 2-hour fasting period for clear oral fluid (including water, pulp-free juice and tea or coffee without milk), 4- hour fasting period for breast milk and 6-hour fasting period for non-human milk and solid food. However, there are only few supportive and suggestive scientific evidences. The purpose of this study is to evaluate the current clinical practice guidelines for preoperative fasting to enhance the quality of pediatric anesthesia care and promote patient safety.The investigators plan to enroll adults aged 18-60 years, who are scheduled for esophago-gastro-duodenoscopy (EGD), in order to study the effects of fasting time and the actual intragastric volume which may help us establish a comprehensive fasting guideline.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
280

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 6, 2020

Completed
26 days until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

March 22, 2023

Status Verified

March 1, 2023

Enrollment Period

3.2 years

First QC Date

August 3, 2020

Last Update Submit

March 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Residual gastric volume

    Collect actual intra-gastric content volume after drinking assigned amount of fluid at 2-hour fasting period of each patient.

    at 2 hour after drinking, during endoscopic procedure

Secondary Outcomes (4)

  • Gastric acidity (pH)

    at 2 hour after drinking, during endoscopic procedure

  • Hypotension

    at 2 hour after drinking, during endoscopic procedure

  • Post operative nausea and vomitting

    pre-endoscopic procedure

  • Ready to discharge time

    When the procedure finish until ready to discharge, approximately 1-2 hours after endoscopy

Study Arms (4)

0 ml/kg

NO INTERVENTION

The participants will not be asked to drink anything at 2 hours prior to planned procedure.

3 ml/kg

ACTIVE COMPARATOR

The participants will be asked to drink 3ml/kg of clear liquid at 2 hours prior to planned procedure.

Other: Clear liquid intake

7 ml/kg

ACTIVE COMPARATOR

The participants will be asked to drink 7 ml/kg of clear liquid at 2 hours prior to planned procedure.

Other: Clear liquid intake

10 ml/kg

ACTIVE COMPARATOR

The participants will be asked to drink 10 ml/kg of clear liquid at 2 hours prior to planned procedure.

Other: Clear liquid intake

Interventions

Clear oral fluid including water, pulp-free juice and tea or coffee without milk

10 ml/kg3 ml/kg7 ml/kg

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients who are 18-60 years scheduled for EGD procedure
  • Patient who willing to participate in this study

You may not qualify if:

  • Patient who scheduled for emergent EGD procedures
  • Patients with active upper GI bleeding
  • Patients who received preoperative oral medication
  • BMI \> 30 kg/m2
  • Patients with previous GI motility or acid-base pathology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, Siriraj hospital

Bangkok Noi, Bangkok, 10700, Thailand

RECRUITING

MeSH Terms

Conditions

Fasting

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Central Study Contacts

Sirirat Rattanaarpa, MD

CONTACT

Patcharee Sriswasdi, MD, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2020

First Posted

August 6, 2020

Study Start

September 1, 2020

Primary Completion

December 1, 2023

Study Completion

December 1, 2024

Last Updated

March 22, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations